{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:24:33Z","timestamp":1789698273184,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbadis.2025.167666","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T08:51:36Z","timestamp":1737363096000},"page":"167666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unlocking the therapeutic potential of canagliflozin in NAFLD: Insights into AMPK\/SIRT1-mediated lipophagy"],"prefix":"10.1016","volume":"1871","author":[{"given":"Nahla E.","family":"El-Ashmawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"Al-Ashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa A.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman G.","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167666_bb0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0010","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbadis.2025.167666_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and its management","volume":"35","author":"Mundi","year":"2020","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.bbadis.2025.167666_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1615\/CritRevOncog.2020035839","article-title":"Understanding the alterations in lipid metabolism in nafld progression: current trends and future directions","volume":"26","author":"Mungamuri","year":"2021","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.bbadis.2025.167666_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2020.601627","article-title":"The role of lipophagy in the development and treatment of non-alcoholic fatty liver disease","volume":"11","author":"Grefhorst","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbadis.2025.167666_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/livers2010003","article-title":"Oxidative stress in non-alcoholic fatty liver disease","volume":"2","author":"Smirne","year":"2022","journal-title":"Livers"},{"key":"10.1016\/j.bbadis.2025.167666_bb0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fphys.2020.00850","article-title":"Lipophagy impairment is associated with disease progression in NAFLD","volume":"11","author":"Carotti","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112517","article-title":"Emerging role of natural lipophagy modulators in MASLD","author":"El-Ashmawy","year":"2024","journal-title":"Nutrition"},{"key":"10.1016\/j.bbadis.2025.167666_bb0045","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0055","first-page":"7","article-title":"The sirtuin family in health and disease","author":"Wu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.167666_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105770","article-title":"Isoliquiritigenin attenuates non-alcoholic fatty liver disease via the amelioration of hepatic inflammation and autophagy in mice","volume":"109","author":"Jian","year":"2023","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bbadis.2025.167666_bb0065","first-page":"1","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by enhancing energy expenditure and regulating autophagy via AMPK","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114319","article-title":"Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK\/SIRT1 signaling pathway","volume":"160","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.167666_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-022-03697-9","article-title":"Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1\/AMPK signaling pathway","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.bbadis.2025.167666_bb0080","first-page":"15","article-title":"Diagnosis and treatment of liver disease: current trends and future directions","author":"Wazir","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bbadis.2025.167666_bb0085","first-page":"22","article-title":"The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction following in vitro vascular ischemia\/reperfusion injury in rats","author":"Korkmaz-Ic\u00f6z","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167666_bb0090","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","article-title":"Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling\/autophagy hypothesis","volume":"146","author":"Packer","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2025.167666_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13105-023-00974-0","article-title":"The SGLT2 inhibitor empagliflozin attenuates atherosclerosis progression by inducing autophagy","volume":"80","author":"Xu","year":"2024","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.bbadis.2025.167666_bb0100","first-page":"1","article-title":"Dapagliflozin alleviates hepatic steatosis by restoring autophagy via the AMPK-mTOR pathway","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0105","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jgh.15202","article-title":"The impact of sodium glucose co-transporter 2 inhibitors on non-alcoholic fatty liver disease","volume":"36","author":"Chrysavgis","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.biopha.2018.10.049","article-title":"Docosahexaenoic acid-flurbiprofen combination ameliorates metaflammation in rats fed on high-carbohydrate high-fat diet","volume":"109","author":"El-Ashmawy","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.167666_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119731","article-title":"Canagliflozin ameliorates aortic and hepatic dysfunction in dietary-induced hypercholesterolemia in the rabbit","volume":"280","author":"Ashry","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2025.167666_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep26165","article-title":"Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis","volume":"6","author":"Ranjan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167666_bb0125","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/neu.2017.5414","article-title":"Chloroquine promotes the recovery of acute spinal cord injury by inhibiting autophagy-associated inflammation and endoplasmic reticulum stress","volume":"35","author":"Wu","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbadis.2025.167666_bb0130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.111.300483","article-title":"Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation","volume":"112","author":"Long","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2025.167666_bb0135","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1152\/japplphysiol.00586.2012","article-title":"Preventive role of exercise training in autonomic, hemodynamic, and metabolic parameters in rats under high risk of metabolic syndrome development","volume":"114","author":"Moraes-Silva","year":"2013","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2025.167666_bb0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2025.167666_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6960-9_1","article-title":"Basic colorimetric proliferation assays: MTT, WST, and resazurin","volume":"1601","author":"Pr\u00e4bst","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0155","article-title":"Proteomic evaluation of cancer cells: identification of cell surface proteins","volume":"731","author":"Larkin","year":"2011"},{"key":"10.1016\/j.bbadis.2025.167666_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnut.2022.861664","article-title":"Impact of dietary palmitic acid on lipid metabolism","volume":"9","author":"Murru","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bbadis.2025.167666_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mce.2016.06.003","article-title":"Zinc alpha2 glycoprotein alleviates palmitic acid-induced intracellular lipid accumulation in hepatocytes","volume":"439","author":"Xiao","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0170","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/nu14112358","article-title":"11\u03b2-HSD1 inhibitor alleviates non-alcoholic fatty liver disease by activating the AMPK\/SIRT1 signaling pathway","volume":"14","author":"Chen","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2025.167666_bb0175","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.biopha.2018.10.077","article-title":"Involvement of AMPK activation in the inhibition of hepatic gluconeogenesis by Ficus carica leaf extract in diabetic mice and HepG2 cells","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.167666_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2017.09.049","article-title":"Baicalin and its metabolites suppresses gluconeogenesis through activation of AMPK or AKT in insulin resistant HepG-2 cells","volume":"141","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.167666_bb0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.bbadis.2025.167666_bb0195","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/ijo.2017.90","article-title":"Grape seed proanthocyanidin supplementation reduces adipocyte size and increases adipocyte number in obese rats","volume":"41","author":"Pascual-Serrano","year":"2017","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbadis.2025.167666_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11901-019-00500-1","article-title":"NAFLD histology: a critical review and comparison of scoring systems","volume":"18","author":"Pai","year":"2019","journal-title":"Curr. Hepatol. Rep."},{"key":"10.1016\/j.bbadis.2025.167666_bb0205","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00428-011-1147-1","article-title":"A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies","volume":"459","author":"Catta-Preta","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbadis.2025.167666_bb0210","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","article-title":"Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease","volume":"8","author":"Mehlem","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbadis.2025.167666_bb0215","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.2147\/OTT.S88592","article-title":"The expression of the PI3K\/AKT\/mTOR pathway in gastric cancer and its role in gastric cancer prognosis","volume":"8","author":"Ying","year":"2015","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bbadis.2025.167666_bb0220","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3748\/wjg.v16.i23.2851","article-title":"Fixation methods for electron microscopy of human and other liver","volume":"16","author":"Wisse","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0225","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3892\/etm.2016.3069","article-title":"Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: an in vitro model of non-alcoholic fatty liver disease","volume":"11","author":"Alkhatatbeh","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbadis.2025.167666_bb0230","first-page":"23","article-title":"Pathogenesis and therapeutic strategies related to non-alcoholic fatty liver disease","author":"Teng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167666_bb0235","first-page":"197","article-title":"Metabolic dysfunction-associated Steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"Asia Diabetes Found"},{"key":"10.1016\/j.bbadis.2025.167666_bb0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/dom.14251","article-title":"Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: an Asian perspective and expert recommendations","volume":"23","author":"Khoo","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2025.167666_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108503","article-title":"Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation","volume":"104","author":"Hazem","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0250","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2215\/CJN.11480821","article-title":"SGLT2 inhibition and uric acid excretion in patients with type 2 diabetes and normal kidney function","volume":"17","author":"Suijk","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-022-01512-w","article-title":"The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management","volume":"21","author":"Xu","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-13-102","article-title":"Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOMETM)","volume":"13","author":"Zinman","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0265","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3177\/jnsv.69.357","article-title":"The effects of overnight fasting duration on glucose and lipid metabolism in a Sprague-Dawley rat model of nonalcoholic steatohepatitis with advanced fibrosis","volume":"69","author":"Omagari","year":"2023","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.bbadis.2025.167666_bb0270","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0023677213501659","article-title":"Fasting of mice: a review","volume":"47","author":"Jensen","year":"2013","journal-title":"Lab. Anim."},{"key":"10.1016\/j.bbadis.2025.167666_bb0275","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3349\/ymj.2022.63.7.619","article-title":"Canagliflozin ameliorates nonalcoholic fatty liver disease by regulating lipid metabolism and inhibiting inflammation through induction of autophagy","volume":"63","author":"Xu","year":"2022","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.bbadis.2025.167666_bb0280","first-page":"8","article-title":"Canagliflozin protects against cisplatin-induced acute kidney injury by AMPK-mediated autophagy in renal proximal tubular cells","author":"Park","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167666_bb0285","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bcp.2018.03.013","article-title":"Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells","volume":"152","author":"Xu","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22020818","article-title":"Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE(\u2212\/\u2212) mice by activating autophagy and reducing ER stress and apoptosis","volume":"22","author":"Nasiri-Ansari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167666_bb0295","first-page":"1","article-title":"Improving lipophagy by restoring Rab7 cycle: protective effects of quercetin on ethanol-induced liver steatosis","volume":"14","author":"Lin","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.bbadis.2025.167666_bb0300","first-page":"1","article-title":"The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2025.167666_bb0305","first-page":"686","article-title":"Lipophagy: molecular mechanisms and implications in metabolic disorders","volume":"43","author":"Shin","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2025.167666_bb0310","doi-asserted-by":"crossref","first-page":"G726","DOI":"10.1152\/ajpgi.00436.2015","article-title":"Liver-specific loss of perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis","volume":"310","author":"Najt","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0315","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13679-021-00431-3","article-title":"Endoplasmic reticulum stress and autophagy in the pathogenesis of non-alcoholic fatty liver disease (NAFLD): current evidence and perspectives","volume":"10","author":"Flessa","year":"2021","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.bbadis.2025.167666_bb0320","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/jcb.30247","article-title":"Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD\/MAFLD)","volume":"123","author":"Flessa","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2025.167666_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2021.758311","article-title":"Crosstalk between ER stress, autophagy and inflammation","volume":"8","author":"Chipurupalli","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bbadis.2025.167666_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2022.1015500","article-title":"Role of AMPK in autophagy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0335","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1440-1681.13638","article-title":"Dapagliflozin attenuates high glucose-induced endothelial cell apoptosis and inflammation through AMPK\/SIRT1 activation","volume":"49","author":"Faridvand","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbadis.2025.167666_bb0340","doi-asserted-by":"crossref","first-page":"921","DOI":"10.4093\/dmj.2020.0187","article-title":"Ipragliflozin, an SGLT2 inhibitor, ameliorates high-fat diet-induced metabolic changes by upregulating energy expenditure through activation of the AMPK\/SIRT1 pathway","volume":"45","author":"Lee","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.bbadis.2025.167666_bb0345","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2025.167666_bb0350","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbadis.2025.167666_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-23420-4","article-title":"Canagliflozin inhibits interleukin-1\u03b2-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms","volume":"8","author":"Mancini","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167666_bb0360","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10557-020-07083-w","article-title":"Novel anti-inflammatory effects of canagliflozin involving hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells","volume":"35","author":"Uthman","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bbadis.2025.167666_bb0365","first-page":"1","article-title":"Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK\u2013Akt\u2013eNOS pathway in the isoprenaline-induced oxidative stress model","volume":"10","author":"Hasan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2025.167666_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113409","article-title":"Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK\/NF-\u03baB\/NLRP3 axis: a new paradigm in the rectal therapy of ulcerative colitis","volume":"153","author":"Nasr","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:12:02Z","timestamp":1772457122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0925443925000110"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167666","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the therapeutic potential of canagliflozin in NAFLD: Insights into AMPK\/SIRT1-mediated lipophagy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167666","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167666"}}